The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 03, 2015

Filed:

Mar. 27, 2008
Applicants:

Marianna Foldvari, Kitchener, CA;

Praveen Kumar, Saskatoon, CA;

John M. Docherty, Richmond Hill, CA;

Inventors:

Marianna Foldvari, Kitchener, CA;

Praveen Kumar, Saskatoon, CA;

John M. Docherty, Richmond Hill, CA;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/21 (2006.01); A61K 9/127 (2006.01); A61K 38/00 (2006.01); A61K 9/00 (2006.01); A61K 31/198 (2006.01); A61K 47/18 (2006.01); A61K 9/10 (2006.01); A61K 9/107 (2006.01);
U.S. Cl.
CPC ...
A61K 9/127 (2013.01); A61K 9/0034 (2013.01); A61K 9/1277 (2013.01); A61K 31/198 (2013.01); A61K 38/21 (2013.01); A61K 47/183 (2013.01); A61K 38/212 (2013.01); A61K 9/10 (2013.01); A61K 9/1075 (2013.01);
Abstract

A biphasic lipid vesicle composition for treating cervical displasia by intravaginal delivery. The composition includes a suspension of lipid-bilayer vesicles having entrapped therein, an oil-in-water emulsion, human interferon alpha-2b and L-methionine, the composition having an interferon alpha-2b specific activity of between about 1-10 MIU (million international units) per gram composition, and between 0.01 to 0.5 weight percent L-methionine. In the treatment method, the composition is administered at a dose of between about 1-20 MIU interferon alpha-2b, and this dose is administered at least 3 days/week, for a period of at least 4 weeks.


Find Patent Forward Citations

Loading…